A citation-based method for searching scientific literature

Maria C Katapodi, Chang Ming, Laurel L Northouse, Sonia A Duffy, Debra Duquette, Kari E Mendelsohn-Victor, Kara J Milliron, Sofia D Merajver, Ivo D Dinov, Nancy K Janz. Cancers (Basel) 2020
Times Cited: 2







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients.
Erna Claes, Gerry Evers-Kiebooms, Andrea Boogaerts, Marleen Decruyenaere, Lieve Denayer, Eric Legius. Am J Med Genet A 2003
158
100

How to inform at-risk relatives? Attitudes of 1379 Dutch patients, relatives, and members of the general population.
Lieke Marleen van den Heuvel, Daphne Stemkens, Wendy A G van Zelst-Stams, Floor Willeboordse, Imke Christiaans. J Genet Couns 2020
4
50

Availability and payer coverage of BRCA1/2 tests and gene panels.
Elizabeth Clain, Julia R Trosman, Michael P Douglas, Christine B Weldon, Kathryn A Phillips. Nat Biotechnol 2015
17
50

A tailored Web-based psychoeducational intervention for cancer patients and their family caregivers.
Laurel Northouse, Ann Schafenacker, Kathryn L C Barr, Maria Katapodi, Hyojin Yoon, Kelly Brittain, Lixin Song, David L Ronis, Larry An. Cancer Nurs 2014
69
50

Recruiting families at risk for hereditary breast and ovarian cancer from a statewide cancer registry: a methodological study.
Maria C Katapodi, Deb Duquette, James J Yang, Kari Mendelsohn-Victor, Beth Anderson, Christos Nikolaidis, Emily Mancewicz, Laurel L Northouse, Sonia Duffy, David Ronis,[...]. Cancer Causes Control 2017
14
50

Validation of a decision regret scale.
Jamie C Brehaut, Annette M O'Connor, Timothy J Wood, Thomas F Hack, Laura Siminoff, Elisa Gordon, Deb Feldman-Stewart. Med Decis Making 2003
588
50

Challenges in managing genetic cancer risk: a long-term qualitative study of unaffected women carrying BRCA1/BRCA2 mutations.
Maria Caiata-Zufferey, Olivia Pagani, Viviane Cina, Véronique Membrez, Monica Taborelli, Sheila Unger, Anne Murphy, Christian Monnerat, Pierre O Chappuis. Genet Med 2015
7
50

What motivates interest in attending a familial cancer genetics clinic?
L Fraser, S Bramald, C Chapman, C Chu, V Cornelius, F Douglas, A Lucassen, A Nehammer, S Sutton, M Trivella,[...]. Fam Cancer 2003
26
50

Genetic counseling for BRCA1/2: a randomized controlled trial of two strategies to facilitate the education and counseling process.
Catharine Wang, Richard Gonzalez, Kara J Milliron, Victor J Strecher, Sofia D Merajver. Am J Med Genet A 2005
54
50

Launching a virtual decision lab: development and field-testing of a web-based patient decision support research platform.
Aubri S Hoffman, Hilary A Llewellyn-Thomas, Anna N A Tosteson, Annette M O'Connor, Robert J Volk, Ivan M Tomek, Steven B Andrews, Stephen J Bartels. BMC Med Inform Decis Mak 2014
22
50

Minimal intervention needed for change: definition, use, and value for improving health and health research.
Russell E Glasgow, Lawrence Fisher, Lisa A Strycker, Danielle Hessler, Deborah J Toobert, Diane K King, Tom Jacobs. Transl Behav Med 2014
39
50

Underestimation of breast cancer risk: influence on screening behavior.
Maria C Katapodi, Marylin J Dodd, Kathryn A Lee, Noreen C Facione. Oncol Nurs Forum 2009
48
50

The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study.
Eunyoung Kang, Moon-Woo Seong, Sue K Park, Jong Won Lee, Jihyoun Lee, Lee Su Kim, Jeong Eon Lee, Sung Yong Kim, Joon Jeong, Sang Ah Han,[...]. Breast Cancer Res Treat 2015
51
50

BRCA1/2 mutations in Swiss patients with familial or early-onset breast and ovarian cancer.
F Schoumacher, A Glaus, H Mueller, U Eppenberger, B Bolliger, H J Senn. Swiss Med Wkly 2001
10
50

Development of a Web-based Family Intervention for BRCA Carriers and Their Biological Relatives: Acceptability, Feasibility, and Usability Study.
Maria C Katapodi, Miyeon Jung, Ann M Schafenacker, Kara J Milliron, Kari E Mendelsohn-Victor, Sofia D Merajver, Laurel L Northouse. JMIR Cancer 2018
10
50

Psychometric testing of the decisional conflict scale: genetic testing hereditary breast and ovarian cancer.
Maria C Katapodi, Michelle L Munro, Penny F Pierce, Reg A Williams. Nurs Res 2011
18
50


South Korea: in the midst of a privacy reform centered on data sharing.
Hannah Kim, So Yoon Kim, Yann Joly. Hum Genet 2018
6
50

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.
J Ferlay, E Steliarova-Foucher, J Lortet-Tieulent, S Rosso, J W W Coebergh, H Comber, D Forman, F Bray. Eur J Cancer 2013
50

An exploration of the communication preferences regarding genetic testing in individuals from families with identified breast/ovarian cancer mutations.
Paboda Ratnayake, Claire E Wakefield, Bettina Meiser, Graeme Suthers, Melanie A Price, Jessica Duffy, Kathy Tucker. Fam Cancer 2011
23
50

Barriers and facilitators for utilization of genetic counseling and risk assessment services in young female breast cancer survivors.
Beth Anderson, Jennifer McLosky, Elizabeth Wasilevich, Sarah Lyon-Callo, Debra Duquette, Glenn Copeland. J Cancer Epidemiol 2012
61
50

KOHBRA BRCA risk calculator (KOHCal): a model for predicting BRCA1 and BRCA2 mutations in Korean breast cancer patients.
Eunyoung Kang, Sue K Park, Jong Won Lee, Zisun Kim, Woo-Chul Noh, Yongsik Jung, Jung-Hyun Yang, Sung Hoo Jung, Sung-Won Kim. J Hum Genet 2016
9
50


Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk.
Jennifer L Caswell-Jin, Tanya Gupta, Evan Hall, Iva M Petrovchich, Meredith A Mills, Kerry E Kingham, Rachel Koff, Nicolette M Chun, Peter Levonian, Alexandra P Lebensohn,[...]. Genet Med 2018
54
50

Expert and Advocacy Group Consensus Findings on the Horizon of Public Health Genetic Testing.
Stephen M Modell, Karen Greendale, Toby Citrin, Sharon L R Kardia. Healthcare (Basel) 2016
14
50

Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol.
Maria C Katapodi, Valeria Viassolo, Maria Caiata-Zufferey, Christos Nikolaidis, Rosmarie Bührer-Landolt, Nicole Buerki, Rossella Graffeo, Henrik Csaba Horváth, Christian Kurzeder, Manuela Rabaglio,[...]. JMIR Res Protoc 2017
12
50


Returning to Earth: Setting a Global Agenda for the Anthropology of Cancer.
Nancy J Burke, Holly F Mathews. Med Anthropol 2017
3
50

Individual and family characteristics associated with BRCA1/2 genetic testing in high-risk families.
Maria C Katapodi, Laurel L Northouse, Kara J Milliron, Guipeng Liu, Sofia D Merajver. Psychooncology 2013
14
50

The influence of social support on breast cancer screening in a multicultural community sample.
Maria C Katapodi, Noreen C Facione, Christine Miaskowski, Marilyn J Dodd, Catherine Waters. Oncol Nurs Forum 2002
73
50

Features of Computer-Based Decision Aids: Systematic Review, Thematic Synthesis, and Meta-Analyses.
Ania Syrowatka, Dörthe Krömker, Ari N Meguerditchian, Robyn Tamblyn. J Med Internet Res 2016
43
50

Reproductive factors as risk modifiers of breast cancer in BRCA mutation carriers and high-risk non-carriers.
Boyoung Park, John L Hopper, Aung K Win, James G Dowty, Ho Kyung Sung, Choonghyun Ahn, Sung-Won Kim, Min Hyuk Lee, Jihyoun Lee, Jong Won Lee,[...]. Oncotarget 2017
11
50

Breast cancer statistics, 2019.
Carol E DeSantis, Jiemin Ma, Mia M Gaudet, Lisa A Newman, Kimberly D Miller, Ann Goding Sauer, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2019
644
50


Minimum standards for the certification of patient decision support interventions: feasibility and application.
Marie-Anne Durand, Jana Witt, Natalie Joseph-Williams, Robert G Newcombe, Mary C Politi, Stephanie Sivell, Glyn Elwyn. Patient Educ Couns 2015
38
50

Challenges and Opportunities for Cancer Predisposition Cascade Screening for Hereditary Breast and Ovarian Cancer and Lynch Syndrome in Switzerland: Findings from an International Workshop.
Christos Nikolaidis, Chang Ming, Carla Pedrazzani, Tina van der Horst, Andrea Kaiser-Grolimund, Zanfina Ademi, Rosmarie Bührer-Landolt, Nicole Bürki, Maria Caiata-Zufferey, Victoria Champion,[...]. Public Health Genomics 2018
7
50


Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
50


Development of FamilyTalk: an Intervention to Support Communication and Educate Families About Colorectal Cancer Risk.
Deborah J Bowen, Travis Hyams, Mercy Laurino, Timothy Woolley, Stacey Cohen, Kathleen A Leppig, Gail Jarvik. J Cancer Educ 2020
6
50

Population screening for genetic disorders in the 21st century: evidence, economics, and ethics.
S D Grosse, W H Rogowski, L F Ross, M C Cornel, W J Dondorp, M J Khoury. Public Health Genomics 2010
83
50




Development of the Informing Relatives Inventory (IRI): Assessing Index Patients' Knowledge, Motivation and Self-Efficacy Regarding the Disclosure of Hereditary Cancer Risk Information to Relatives.
Eveline de Geus, Cora M Aalfs, Fred H Menko, Rolf H Sijmons, Mathilde G E Verdam, Hanneke C J M de Haes, Ellen M A Smets. Int J Behav Med 2015
8
50

Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer.
Joan L Walker, C Bethan Powell, Lee-May Chen, Jeanne Carter, Victoria L Bae Jump, Lynn P Parker, Mark E Borowsky, Randall K Gibb. Cancer 2015
135
50

Population prevalence of individuals meeting criteria for hereditary breast and ovarian cancer testing.
Samantha Greenberg, Saundra S Buys, Sandra L Edwards, Whitney Espinel, Alison Fraser, Amanda Gammon, Brent Hafen, Kimberly A Herget, Wendy Kohlmann, Camille Roundy,[...]. Cancer Med 2019
5
50


Physicians communicating with women at genetic risk of breast and ovarian cancer: Are we in the middle of the ford between contradictory messages and unshared decision making?
Marta Fadda, Pierre O Chappuis, Maria C Katapodi, Olivia Pagani, Christian Monnerat, Véronique Membrez, Sheila Unger, Maria Caiata Zufferey. PLoS One 2020
2
50

Telegenetics use in presymptomatic genetic counselling: patient evaluations on satisfaction and quality of care.
Ellen Otten, Erwin Birnie, Adelita V Ranchor, Irene M van Langen. Eur J Hum Genet 2016
23
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.